table of content
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy in CNS Disorder Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy in CNS Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy in CNS Disorder Overall Market Size
2.1 Global Gene Therapy in CNS Disorder Market Size: 2023 VS 2030
2.2 Global Gene Therapy in CNS Disorder Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy in CNS Disorder Players in Global Market
3.2 Top Global Gene Therapy in CNS Disorder Companies Ranked by Revenue
3.3 Global Gene Therapy in CNS Disorder Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy in CNS Disorder Companies in Global Market, by Revenue in 2023
3.5 Global Companies Gene Therapy in CNS Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy in CNS Disorder Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy in CNS Disorder Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy in CNS Disorder Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy in CNS Disorder Market Size Markets, 2023 & 2030
4.1.2 Viral Gene Therapy
4.1.3 Non-viral Gene Therapy
4.2 By Type - Global Gene Therapy in CNS Disorder Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy in CNS Disorder Revenue, 2019-2024
4.2.2 By Type - Global Gene Therapy in CNS Disorder Revenue, 2025-2030
4.2.3 By Type - Global Gene Therapy in CNS Disorder Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy in CNS Disorder Market Size, 2023 & 2030
5.1.2 Alzheimer's Disease
5.1.3 Huntington's Disease
5.1.4 Parkinson's Disease
5.1.5 Batten Disease
5.2 By Application - Global Gene Therapy in CNS Disorder Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy in CNS Disorder Revenue, 2019-2024
5.2.2 By Application - Global Gene Therapy in CNS Disorder Revenue, 2025-2030
5.2.3 By Application - Global Gene Therapy in CNS Disorder Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Gene Therapy in CNS Disorder Market Size, 2023 & 2030
6.2 By Region - Global Gene Therapy in CNS Disorder Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy in CNS Disorder Revenue, 2019-2024
6.2.2 By Region - Global Gene Therapy in CNS Disorder Revenue, 2025-2030
6.2.3 By Region - Global Gene Therapy in CNS Disorder Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Gene Therapy in CNS Disorder Revenue, 2019-2030
6.3.2 US Gene Therapy in CNS Disorder Market Size, 2019-2030
6.3.3 Canada Gene Therapy in CNS Disorder Market Size, 2019-2030
6.3.4 Mexico Gene Therapy in CNS Disorder Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Gene Therapy in CNS Disorder Revenue, 2019-2030
6.4.2 Germany Gene Therapy in CNS Disorder Market Size, 2019-2030
6.4.3 France Gene Therapy in CNS Disorder Market Size, 2019-2030
6.4.4 U.K. Gene Therapy in CNS Disorder Market Size, 2019-2030
6.4.5 Italy Gene Therapy in CNS Disorder Market Size, 2019-2030
6.4.6 Russia Gene Therapy in CNS Disorder Market Size, 2019-2030
6.4.7 Nordic Countries Gene Therapy in CNS Disorder Market Size, 2019-2030
6.4.8 Benelux Gene Therapy in CNS Disorder Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Gene Therapy in CNS Disorder Revenue, 2019-2030
6.5.2 China Gene Therapy in CNS Disorder Market Size, 2019-2030
6.5.3 Japan Gene Therapy in CNS Disorder Market Size, 2019-2030
6.5.4 South Korea Gene Therapy in CNS Disorder Market Size, 2019-2030
6.5.5 Southeast Asia Gene Therapy in CNS Disorder Market Size, 2019-2030
6.5.6 India Gene Therapy in CNS Disorder Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Gene Therapy in CNS Disorder Revenue, 2019-2030
6.6.2 Brazil Gene Therapy in CNS Disorder Market Size, 2019-2030
6.6.3 Argentina Gene Therapy in CNS Disorder Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy in CNS Disorder Revenue, 2019-2030
6.7.2 Turkey Gene Therapy in CNS Disorder Market Size, 2019-2030
6.7.3 Israel Gene Therapy in CNS Disorder Market Size, 2019-2030
6.7.4 Saudi Arabia Gene Therapy in CNS Disorder Market Size, 2019-2030
6.7.5 UAE Gene Therapy in CNS Disorder Market Size, 2019-2030
7 Gene Therapy in CNS Disorder Companies Profiles
7.1 Voyager Therapeutics
7.1.1 Voyager Therapeutics Company Summary
7.1.2 Voyager Therapeutics Business Overview
7.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Major Product Offerings
7.1.4 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue in Global Market (2019-2024)
7.1.5 Voyager Therapeutics Key News & Latest Developments
7.2 Spark Therapeutics
7.2.1 Spark Therapeutics Company Summary
7.2.2 Spark Therapeutics Business Overview
7.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Major Product Offerings
7.2.4 Spark Therapeutics Gene Therapy in CNS Disorder Revenue in Global Market (2019-2024)
7.2.5 Spark Therapeutics Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Gene Therapy in CNS Disorder Major Product Offerings
7.3.4 Novartis AG Gene Therapy in CNS Disorder Revenue in Global Market (2019-2024)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Bluebird Bio Inc.
7.4.1 Bluebird Bio Inc. Company Summary
7.4.2 Bluebird Bio Inc. Business Overview
7.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Major Product Offerings
7.4.4 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue in Global Market (2019-2024)
7.4.5 Bluebird Bio Inc. Key News & Latest Developments
7.5 Biogen
7.5.1 Biogen Company Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Gene Therapy in CNS Disorder Major Product Offerings
7.5.4 Biogen Gene Therapy in CNS Disorder Revenue in Global Market (2019-2024)
7.5.5 Biogen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
